Zimmer Biomet, Inc. recalls SpF PLUS-Mini (60 ¿A/W) Implantable Spinal Fusion Stimulator SpF PLUS-Mini Implantable Fusion Stimulators are indicated…
- Recall date
- February 19, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0287-2019
- FDA classification
- Class I
- Brand / firm
- Zimmer Biomet, Inc.
- Sold / distributed
- US Nationwide Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV ; and country of: Australia.
Why it was recalled
Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
SpF PLUS-Mini (60 ¿A/W) Implantable Spinal Fusion Stimulator SpF PLUS-Mini Implantable Fusion Stimulators are indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels
Get recall alerts
Free email alert whenever Zimmer Biomet, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Zimmer Biomet, Inc.